Evidence map›Paper›PMID 42154219›Full record

ArticleHerzschrittmachertherapie & Elektrophysiologie2026

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].

Daniel Steven, Julian Chun, Isabel Deisenhofer, Thomas Deneke, Maria Papathanasiou, Boris Schmidt, Andreas Rillig, Stephan Willems, Maura M Zylla, Christian Veltmann and 2 more

Abstract readConsensus StatementEnglish Abstract
In one paragraph

Article in Herzschrittmachertherapie & Elektrophysiologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel StevenAbteilung für Elektrophysiologie, Herzzentrum Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. daniel.steven@uk-koeln.de.
Julian ChunMedizinische Klinik III - CCB, Agaplesion Markus Krankenhaus, Frankfurt am Main, Deutschland.
Isabel DeisenhoferAbteilung für Elektrophysiologie, Deutsches Herzzentrum München, München, Deutschland.
Thomas DenekeKlinik für Kardiologie und Rhythmologie, Klinikum Nürnberg Süd, Nürnberg, Deutschland.
Maria PapathanasiouMed. Klinik III - Kardiologie, Angiologie, Universitätsklinikum Frankfurt, Frankfurt am Main, Deutschland.
Boris SchmidtMedizinische Klinik III - CCB, Agaplesion Markus Krankenhaus, Frankfurt am Main, Deutschland.
Andreas RilligKlinik für Kardiologie mit Schwerpunkt Elektrophysiologie, Universitäres Herz- und Gefäßzentrum Hamburg, Hamburg, Deutschland.
Stephan WillemsKardiologie & internistische Intensivmedizin, Asklepios Klinik St. Georg, Hamburg, Deutschland.
Maura M ZyllaKlinik für Innere Med. III, Kardiologie, Angiologie u. Pneumologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Christian VeltmannElektrophysiologie Bremen im Klinikum Links der Weser, Bremen, Deutschland.
Lars EckardtKlinik für Kardiologie II - Rhythmologie, Universitätsklinikum Münster, Münster, Deutschland.
Kommission für Klinische Kardiovaskuläre Medizin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The updated German Society of Cardiology (DGK) position paper on catheter ablation of atrial fibrillation (AF) [1] presents the current evidence, techniques, and quality standards, which have evolved significantly since 2017 alongside indications, technology, and the role of ablation in therapy. Pulmonary vein isolation (PVI) remains the cornerstone of AF ablation. In addition to established procedures such as radiofrequency and cryoballoon ablation, pulsed field ablation (PFA) is gaining importance. For persistent AF, clear recommendations beyond PVI are still lacking, despite growing evidence supporting adjunctive ablation strategies. The healthcare landscape shows a marked increase in ablations, with same day discharge procedures recommended only for carefully selected patients. Precise patient selection-including medical history, risk factors, and imaging-is critical for procedural success and safety. The importance of periprocedural management and structured follow-up is emphasized. Complications such as pericardial tamponade, stroke, and phrenic nerve injury require structured protocols and experienced teams. Particularly in patients with heart failure, ablation may offer prognostic benefits. Certification of centers by the DGK supports quality assurance. New developments, such as artificial intelligence (AI)-assisted ablation planning and studies on postablation anticoagulation strategies, are expected to further influence clinical practice.

Indexed as

Atrial FibrillationCardiologyCatheter AblationPractice Guidelines as TopicQuality Assurance, Health CareGermanyHumansAnticoagulationArrhythmiaAtrial fibrillationCatheter ablationHeart failure

Identifiers

PMID42154219
PMCPMC13212626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.